Page last updated: 2024-08-21

alpha-aminopyridine and Central Nervous System Neoplasm

alpha-aminopyridine has been researched along with Central Nervous System Neoplasm in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Desmarais, M; Fitzwalter, BE; Foreman, NK; Green, AL; Grob, S; Hankinson, TC; Morin, A; Mulcahy Levy, JM; Nellan, A; Vibhakar, R; Zahedi, S	1
Fujiwara, Y; Naito, T; Shiraishi, H	1
Batchelor, TT; Grommes, C; Nayak, L; Tun, HW	1

Reviews

2 review(s) available for alpha-aminopyridine and Central Nervous System Neoplasm

Article	Year
Brigatinib and lorlatinib: their effect on ALK inhibitors in NSCLC focusing on resistant mutations and central nervous system metastases. Japanese journal of clinical oncology, 2021, Jan-01, Volume: 51, Issue:1 Topics: Aminopyridines; Anaplastic Lymphoma Kinase; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Central Nervous System Neoplasms; Crizotinib; Drug Resistance, Neoplasm; Humans; Lactams; Lactams, Macrocyclic; Lung Neoplasms; Mutation; Organophosphorus Compounds; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines	2021
Introduction of novel agents in the treatment of primary CNS lymphoma. Neuro-oncology, 2019, 02-19, Volume: 21, Issue:3 Topics: Adenine; Agammaglobulinaemia Tyrosine Kinase; Aminopyridines; Antineoplastic Agents, Immunological; Burkitt Lymphoma; Central Nervous System Neoplasms; Humans; Immunologic Factors; Lenalidomide; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell; Morpholines; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Piperidines; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Rituximab; Salvage Therapy; Thalidomide; Toll-Like Receptors; TOR Serine-Threonine Kinases; Tumor Escape	2019

Article

Year

Brigatinib and lorlatinib: their effect on ALK inhibitors in NSCLC focusing on resistant mutations and central nervous system metastases.

Japanese journal of clinical oncology, 2021, Jan-01, Volume: 51, Issue:1

Topics: Aminopyridines; Anaplastic Lymphoma Kinase; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Central Nervous System Neoplasms; Crizotinib; Drug Resistance, Neoplasm; Humans; Lactams; Lactams, Macrocyclic; Lung Neoplasms; Mutation; Organophosphorus Compounds; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines

2021

Introduction of novel agents in the treatment of primary CNS lymphoma.

Neuro-oncology, 2019, 02-19, Volume: 21, Issue:3

Topics: Adenine; Agammaglobulinaemia Tyrosine Kinase; Aminopyridines; Antineoplastic Agents, Immunological; Burkitt Lymphoma; Central Nervous System Neoplasms; Humans; Immunologic Factors; Lenalidomide; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell; Morpholines; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Piperidines; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Rituximab; Salvage Therapy; Thalidomide; Toll-Like Receptors; TOR Serine-Threonine Kinases; Tumor Escape

2019

Other Studies

1 other study(ies) available for alpha-aminopyridine and Central Nervous System Neoplasm

Article	Year
Effect of early-stage autophagy inhibition in BRAF Cell death & disease, 2019, 09-12, Volume: 10, Issue:9 Topics: Aminopyridines; Autophagy; Benzamides; Blotting, Western; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Central Nervous System Neoplasms; Flow Cytometry; Humans; Mutation; Proto-Oncogene Proteins B-raf; Pyrimidines	2019